| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Revenue | $4.07B | +7.8% |
| Cost of Revenue | $2.23B | +6.0% |
| R&D Expense | $132.0M | +17.1% |
| SG&A Expense | $978.8M | +10.3% |
| Operating Income | $859.5M | +10.1% |
| Interest Expense | $101.0M | -1.0% |
| Pre-tax Income | $768.4M | +10.0% |
| Income Tax | $124.6M | +23.0% |
| Net Income | $643.8M |
| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $356.2M | -29.3% |
| Inventory | $519.0M | +22.7% |
| Current Assets | $1.39B | -2.1% |
| Total Assets | $5.22B | +16.4% |
| Current Liabilities | $755.4M | +8.4% |
| Long-term Debt | $1.98B | -1.0% |
| Total Liabilities | $3.16B | +5.7% |
| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | $783.8M | +16.1% |
| Investing Cash Flow | -$685.5M | -200.1% |
| Financing Cash Flow | -$266.7M | +32.4% |
| +7.7% |
| EPS (Basic) | $7.48 | +9.2% |
| EPS (Diluted) | $7.44 | +9.1% |
| Stockholders' Equity |
| $2.07B |
| +37.8% |